[Does bevacizumab have a protective effect on hepatotoxicity induced by chemotherapy?]. [electronic resource]
Producer: 20100504Description: S18-24 p. digitalISSN:- 1773-0422
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- toxicity
- Bevacizumab
- Chemotherapy, Adjuvant
- Colonic Neoplasms -- pathology
- Hepatectomy
- Hepatic Veno-Occlusive Disease -- chemically induced
- Humans
- Liver -- drug effects
- Liver Neoplasms -- drug therapy
- Neoadjuvant Therapy
- Organoplatinum Compounds -- toxicity
- Oxaliplatin
- Protective Agents -- therapeutic use
- Rectal Neoplasms -- pathology
- Time Factors
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.